+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey



Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey



Journal of Human Genetics 51(11): 958-963



Glycogen storage disease type III (GSD III) is an autosomal recessive disorder characterized by excessive accumulation of abnormal glycogen in the liver and/or muscles and caused by deficiency in the glycogen debranching enzyme (AGL). Previous studies have revealed that the spectrum of AGL mutations in GSD III patients depends on ethnic grouping. We investigated nine GSD III patients from Germany, Canada, Afghanistan, Iran, and Turkey and identified six novel AGL mutations: one nonsense (W255X), three deletions (1019delA, 3202-3203delTA, and 1859-1869del11-bp), and two splicing mutations (IVS7 + 5G > A and IVS21 + 5insA), together with three previously reported ones (R864X, W1327X, and IVS21 + 1G > A). All mutations are predicted to lead to premature termination, which abolishes enzyme activity. Our molecular study on GSD III patients of different ethnic ancestry showed allelic heterogeneity of AGL mutations. This is the first AGL mutation report for German, Canadian, Afghan, Iranian and Turkish populations.

(PDF emailed within 0-6 h: $19.90)

Accession: 012993818

Download citation: RISBibTeXText

PMID: 17047887

DOI: 10.1007/s10038-006-0045-x


Related references

Molecular analysis of the AGL gene: identification of 25 novel mutations and evidence of genetic heterogeneity in patients with Glycogen Storage Disease Type III. Genetics in Medicine 12(7): 424-430, 2010

Molecular genetic analysis of 40 patients with glycogen storage disease type Ia: 100% mutation detection rate and 5 novel mutations. Human Mutation 15(1): 115-116, 1999

Mutation Analysis in Glycogen Storage Disease Type III Patients in the Netherlands: Novel Genotype-Phenotype Relationships and Five Novel Mutations in the AGL Gene. Jimd Reports 7: 19-26, 2013

Novel mutations in two Japanese cases of glycogen storage disease type IIIa and a review of the literature of the molecular basis of glycogen storage disease type III. Journal of Inherited Metabolic Disease 23(2): 95-106, March, 2000

Molecular analysis in glycogen storage disease 1 non-A: DHPLC detection of the highly prevalent exon 8 mutations of the G6PT1 gene in German patients. Human Mutation 16(2): 177-177, 2000

Glycogen storage disease type Ia: Molecular diagnosis of 51 Japanese patients and characterization of splicing mutations by analysis of ectopically transcribed mRNA from lymphoblastoid cells. American Journal of Medical Genetics 91(2): 107-112, March 13, 2000

The identification of five novel mutations in the lysosomal acid a-(1-4) glucosidase gene from patients with glycogen storage disease type II. Mutations in brief no. 134. Online. Human Mutation 11(5): 413-413, 1999

Molecular and clinical delineation of 12 patients with glycogen storage disease type III in Western Turkey. Clinica Chimica Acta; International Journal of Clinical Chemistry 439(): 162-167, 2015

Identification of mutations in the glucose-6-phosphatase gene in Czech and Slovak patients with glycogen storage disease type ia, including novel mutations K76N, V166A and 540del5. Human Mutation 16(1): 89-89, 2000

Five novel mutations in the glucose-6-phosphatase gene in patients with glycogen storage disease type I. Journal of Inherited Metabolic Disease 20(SUPPL 1): 81, 1997

Mutations in the glucose-6-phosphatase gene of 46 patients with glycogen storage disease type Ia. Journal of Inherited Metabolic Disease 23(Supplement 1): 163, July, 2000

Three novel mutations in the glucose-6-phosphatase gene of patients with glycogen storage disease type Ia. European Journal of Human Genetics 7(SUPPL 1): 127, July, 1999

A novel point mutation in an acceptor splice site of intron 32 (IVS32 A-12fwdarwG) but no exon 3 mutations in the glycogen debranching enzyme gene in a homozygous patients with glycogen storage disease type IIIb. Human Genetics 102(1): 1-5, 1998